title: Minocycline increases the activity of superoxide dismutase and reduces the concentration of nitric oxide, hydrogen peroxide and mitochondrial malondialdehyde in manganese treated Drosophila melanogaster.
abstract: The toxicity caused by high concentrations of manganese (Mn) could be due to a production of free radicals. Minocycline is an effective antioxidant with a high potential to capture free radicals. We investigated the effect of minocycline in the activities of superoxide dismutase (SOD) and catalase, and in the concentrations of nitric oxide (NO), hydrogen peroxide (H2O2) and mitochondrial malondialdehyde (MDA) in manganese-treated Drosophila melanogaster. Five groups of flies were used: (1) control: not treated; (2) continuously treated with minocycline (0.05 mM); (3) treated with 30 mM Mn for 6 days and then no additional treatment; (4) continuously treated with Mn; (5) treated only with Mn for 6 days and then treated with minocycline; (6) simultaneously treated with Mn and minocycline. On the 6th day, Mn treatment caused 50% mortality; in the surviving flies increased levels of MDA (67.93%), NO (11.04%), H2O2 (14.62%) and SOD and catalase activity (165.34 and 71.43%, respectively) were detected. All the flies continuously treated with Mn died by the 21st day. On day 40, MDA levels were decreased in groups two, three and five (43.04, 29.67, and 34.72% respectively), as well as NO in group two (29.21%) and H2O2 in groups two and five (53.94% and 78.69%, respectively), while in group three the concentration of H2O2 was increased (408.25%). In conclusion, Mn exerted a pro-oxidant effect on the 6th day as shown by the increased levels of oxidative markers. Minocycline extended the lifespan, increased the activity of SOD and reduced the levels of NO, H2O2 and mitochondrial MDA.
authors.affiliation: Laboratorio de Neurobiología, Centro de Investigaciones Biomédicas, Instituto Venezolano de Investigaciones Científicas (IVIC), Hospital Universitario de Maracaibo, 9no Piso, Maracaibo, 4002, Estado Zulia, Venezuela.
authors.forename: Marylú
authors.initials: M
authors.lastname: Mora
authors.forename: Ernesto
authors.initials: E
authors.lastname: Bonilla
authors.forename: Shirley
authors.initials: S
authors.lastname: Medina-Leendertz
authors.forename: Yanauri
authors.initials: Y
authors.lastname: Bravo
authors.forename: José Luis
authors.initials: JL
authors.lastname: Arcaya
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D004331:Drosophila melanogaster; D006861:Hydrogen Peroxide / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008136:Longevity / Q000187:drug effects / Q000502:physiology; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism*; D008345:Manganese / Q000633:toxicity*; D008911:Minocycline / Q000494:pharmacology*; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013482:Superoxide Dismutase / Q000378:metabolism*; D015996:Survival Rate / Q000639:trends
chemical_list: D000975:Antioxidants; D009569:Nitric Oxide; D008345:Manganese; D008315:Malondialdehyde; D006861:Hydrogen Peroxide; D013482:Superoxide Dismutase; D008911:Minocycline
references.citation: Mitochondrion. 2010 Apr;10(3):253-62
references.pmid: 20034597
references.citation: Int J Mol Med. 2008 Jul;22(1):9-16
references.pmid: 18575770
references.citation: Mol Nutr Food Res. 2013 Jul;57(7):1255-69
references.pmid: 23495240
references.citation: Neurotoxicology. 2012 Mar;33(2):162-8
references.pmid: 22281203
references.citation: Mech Ageing Dev. 2008 Jul-Aug;129(7-8):483-91
references.pmid: 18455751
references.citation: Toxicology. 2012 Oct 9;300(1-2):100-1
references.pmid: 22561279
references.citation: Neurotox Res. 2009 Jul;16(1):42-9
references.pmid: 19526297
references.citation: J Neurochem. 2005 Aug;94(3):819-27
references.pmid: 16033424
references.citation: Toxicology. 2012 Mar 29;294(1):50-3
references.pmid: 22330257
references.citation: Toxicol Sci. 2009 Jan;107(1):156-64
references.pmid: 18836210
references.citation: Curr Vasc Pharmacol. 2005 Jul;3(3):209-14
references.pmid: 16026317
references.citation: Biometals. 2011 Dec;24(6):1045-57
references.pmid: 21594680
references.citation: Brain Res. 2008 Oct 21;1236:200-5
references.pmid: 18725210
references.citation: BMC Pharmacol Toxicol. 2013 Apr 18;14:23
references.pmid: 23594835
references.citation: Brain Res. 2006 Apr 26;1085(1):57-67
references.pmid: 16574083
references.citation: J Neurochem. 2011 May;117(4):747-56
references.pmid: 21395586
references.citation: Toxicol Lett. 2007 Sep 10;173(2):88-100
references.pmid: 17669604
references.citation: Environ Health Toxicol. 2011;26:e2011017
references.pmid: 22232721
references.citation: Neurosci Lett. 2012 Jan 6;506(1):136-40
references.pmid: 22085690
references.citation: Toxicol Lett. 2013 Apr 26;218(3):299-307
references.pmid: 23296100
references.citation: Neurosci Lett. 2001 Nov 23;315(1-2):61-4
references.pmid: 11711215
references.citation: Neurotoxicology. 2012 Aug;33(4):881-6
references.pmid: 22202748
references.citation: J Intern Med. 2013 May;273(5):466-77
references.pmid: 23360507
references.citation: Exp Gerontol. 2002 May;37(5):629-38
references.pmid: 11909680
references.citation: PLoS One. 2012;7(3):e33057
references.pmid: 22427945
references.citation: Toxicology. 2013 Mar 8;305:71-8
references.pmid: 23353026
references.citation: Parkinsons Dis. 2012;2012:938528
references.pmid: 22900232
references.citation: J Environ Monit. 2010 Nov;12(11):2062-9
references.pmid: 20820627
references.citation: Metallomics. 2013 Aug;5(8):997-1005
references.pmid: 23771129
references.citation: Curr Pharm Des. 2004;10(6):679-86
references.pmid: 14965330
references.citation: Toxicol Appl Pharmacol. 2005 Jun 15;205(3):271-81
references.pmid: 15922012
references.citation: Brain Res. 2008 Apr 8;1203:1-11
references.pmid: 18313649
references.citation: J Biol Chem. 2011 Feb 18;286(7):4991-5002
references.pmid: 21081502
references.citation: Exp Clin Immunogenet. 1992;9(4):230-40
references.pmid: 1307244